The Food and Drug Administration (FDA) is reopening the comment period for the rescheduling of marijuana. The Agency is taking this action to allow interested persons additional time to submit comments.

Anyone who is interested can submit their comments either electronically or handwritten by September 30, 2019.

See the original article at the Federal Register